Previously, oxytocin up-regulation in skeletal muscle has already been observed following androgen treatment (De Jager et al., 2011), and it has been proposed as a mediator of muscle regeneration and maintenance in sarcopenia (Camerino, 2009b; Elabd et al., 2014). Here, OXT is linked to sarcopenia.